Methods to assess potential reduced exposure products

Nicotine and Tobacco Research

Volumn 7, Issue 6, 2005, Pages 827-844

  Hatsukami, Dorothy K ^a   Giovino, Gary A ^b   Eissenberg, Thomas ^c   Clark, Pamela I ^d   Lawrence, Deirdre ^e   Leischow, Scott ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d BATTELLE MEMORIAL INSTITUTE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOBACCO SMOKE;

ARTICLE; CIGARETTE SMOKING; ENVIRONMENTAL EXPOSURE; GENE IDENTIFICATION; HEALTH HAZARD; HUMAN; MEDICAL EXPERT; MEDICAL RESEARCH; METHODOLOGY; MORBIDITY; MORTALITY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK REDUCTION; SMOKING HABIT;

BIOLOGICAL MARKERS; CLINICAL TRIALS; CONSUMER PARTICIPATION; CONSUMER PRODUCT SAFETY; ENVIRONMENTAL EXPOSURE; HUMANS; RESEARCH DESIGN; SMOKING; SMOKING CESSATION; TOBACCO INDUSTRY; TOBACCO SMOKE POLLUTION; TOBACCO USE DISORDER; UNITED STATES;

EID: 24144470253     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200500266015     Document Type: Article

References (108)

1. Arfken, C. L. and Cicero, T. J. (2003) Postmarketing surveillance for drug abuse. Drug and Alcohol Dependence, 70 (Suppl. 3), pp. S97-S105.
2. Bachman, J. G. and Johnston, L. D. and O'Malley, P. M.(2001) Monitoring the Future: Questionnaire responses from the nation's high school seniors. In Ann Arbor MI: Survey Research Center, Institute for Social Research.
3. Bates, C. and McNeill, A. and Jarvis, M. and Gray, N. (1999) The future of tobacco product regulation and labeling in Europe: Implications for the forthcoming European Union directive. Tobacco Control, 8, pp. 225-235.
4. Biener, L. and Abrams, D. (1991) The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology, 10, pp. 360-365.
5. Bolliger, C. T. and Zellweger, J.-P. and Danielsson, T. and van Biljon, X. and Robidou, A. and Westin, A. and Perruchoud, A. P. and Sawe, U. (2000) Smoking reduction with oral nicotine inhalers: Double blind, randomised clinical trial of efficacy and safety. British Medical Journal, 321, pp. 329-333.
6. Breland, A. B. and Acosta, M. C. and Eissenberg, T. (2003) Tobacco specific nitrosamines and potential reduced exposure products for smokers: A preliminary evaluation of Advance. Tobacco Control, 12, pp. 317-321.
7. Breland, A. B. and Buchhalter, A. R. and Evans, S. E. and Eissenberg, T. (2002) Evaluating acute effects of potential reduced-exposure products for smokers: Clinical laboratory methodology. Nicotine & Tobacco Research, 4(Suppl. 2), pp. 131-140.
8. Breland, A. B. and Evans, S. E. and Buchhalter, A. R. and Eissenberg, T. (2002) Acute effects of Advance: A potential reduced exposure product for smokers. Tobacco Control, 11, pp. 376-378.
9. Brownlee, S. and Leventhal, E. A. and Leventhal, H.(2000) Regulation, self regulation and regulation of the self in maintaining physical health. In Handbook of self-regulation. (pp. 369-416). San Diego: Academic Press. In
10. Buchhalter, A. R. and Schrinel, L. and Eissenberg, T. (2001) Withdrawal-suppressing effects of a novel smoking system: Comparison with own brand, not own brand, and de-nicotinized cigarettes. Nicotine & Tobacco Research, 3, pp. 111-118.
11. Burns, D. (1997) In Estimating the benefits of a risk reduction strategy [pp.]
12. Caraballo, R. S. and Giovino, G. A. and Pechacek, T. F. and Mowery, P. D. and Richter, P. A. (1998) Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. The Journal of the American Medical Association, 280, pp. 135-139.
13. Carpenter, M. and Hughes, J. and Keely, J. (2003) Effect of smoking reduction on later cessation: A pilot experimental study. Nicotine & Tobacco Research, 5, pp. 155-162.
14. Centers for Disease Control and Prevention. (2000) Use of FDA-approved pharmacologic treatments for tobacco dependence in the United States: 1984-1998. Morbidity and Mortality Weekly Report, 49, pp. 665-669.
15. Centers for Disease Control and Prevention. (2001a) Updated guidelines for evaluating public health surveillance systems: Recommendations from the guidelines working group. Morbidity and Mortality Weekly Report, 50(RR-13), pp. 1-35.
16. Centers for Disease Control and Prevention. (2001b) Youth tobacco surveillance-United States, 2000. Morbidity and Mortality Weekly Report, 50(SS-4), pp. 1-84.
17. Clegg Smith K, Wakefield M, Siebel C, Szczypka G, Slater S, Terry-McElrath Y, Emery S, Chaloupka FJ. 2002. Coding the news: The development of a methodological framework for coding and analyzing newspaper coverage of tobacco issues. Retrieved June 29, 2004, from www.impacteen.org/generalarea_PDFs/Newsmethodspaper_smithMAY2002.pdf
18. Cohen, J. (1996) Smokers' knowledge and understanding of advertised tar numbers: Health policy implications. American Journal of Public Health, 86, pp. 18-24.
19. Colby, S. M. and Tiffany, S. T. and Shiffman, S. and Niaura, R. (2000) Measuring nicotine dependence among youth: A review of available approaches and instruments. Drug and Alcohol Dependence, 59(Suppl. 1), pp. S23-S39.
20. Connett, J. E. and Murray, R. P. and Buist, A. S. and Wise, R. A. and Bailey, W. C. and Lindgren, P. G. and Owens, G. R. and Lung Health Study Research Group. (2003) Changes in smoking status affect women more than men: Results of the Lung Health Study. American Journal of Epidemiology, 157, pp. 973-979.
21. Cruz, T. and Jouharzadeh, P.(2003). In Sampling, coupons, and other free stuff: What is the industry up to?
22. Cummings, K. M. and Hyland, A. and Giovino, G. A. and Hastrup, J. and Bauer, J. and Bansal, M. (2004) Are smokers adequately informed about the health risks of smoking and medicinal nicotine. Nicotine & Tobacco Research, 6(Suppl. 3), pp. 333-340.
23. Doll, R. and Peto, R. (1978) Cigarette smoking and bronchial carcinoma: Dose and time relationships among regular smokers and lifelong non-smokers. Journal of Epidemiology and Community Health, 32, pp. 303-313.
24. Eclipse Expert Panel. (2000) A safer cigarette? A comparative study. A consensus report. Inhalation Toxicology, 12(Suppl. 5), pp. 1-48.
25. Emont, S. (1996) Racial differences in the impact of smoking-attributable disease on health care costs in Indiana. Indiana Medicine, 89, pp. 161-164.
26. Etter, J. and Kozlowski, L. T. and Perneger, T. V. (2003) What smokers believe about light and ultralight cigarettes. Preventive Medicine, 36, pp. 92-98.
27. Etter, J. and Laszlo, E. and Zellweger, J. P. and Perrot, C. and Perneger, T. V. (2002) Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: A randomized trial. Journal of Clinical Psychopharmacology, 22, pp. 487-495.
28. Etter, J. and Paernegger, T. and Ronchi, A. (1997) Distributions of smokers by stage: International comparison and association with smoking prevalence. Preventive Medicine, 26, pp. 580-585.
29. Fagerström, K. O.(2000) Nicotine-replacement therapies. In Nicotine and public health. (pp. 199-207). American Public Health Association. In
30. Fagerström, K. O. and Hughes, J. and Callas, P. (2002) Long term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting. Nicotine & Tobacco Research, 4(Suppl.), pp. S141-S145.
31. Fagerström, K. O. and Tejding, R. and Westin, A. and Lunell, E. (1997) Aiding reduction of smoking with nicotine replacement medications: Hope for the recalcitrant smoker? Tobacco Control, 6, pp. 311-316.
32. Farrelly, M. C. and Healton, C. G. and Davis, K. C. and Messeri, P. and Hersey, J. C. and Haviland, M. L. (2002) Getting to the truth: Evaluating national tobacco countermarketing campaigns. American Journal of Public Health, 92, pp. 901-907.
33. Federal Trade Commission.(2000). In "Tar," nicotine, and carbon monoxide of the smoke of 1,294 varieties of domestic cigarettes for the year 1998. Author.
34. Federal Trade Commission. (2003a). In Federal Trade Commission cigarette report for 2001. Author.
35. Federal Trade Commission. (2003b). In Federal Trade Commission smokeless tobacco report for the years 2000 and 2001. Author.
36. Ferrence, R. and Slade, J. and Room, R. and Pope, M. (Eds.). (2000). In Nicotine and public health. American Public Health Association.
37. Flanders, W. D. and Lally, C. A. and Zhu, B. P. and Henley, S. J. and Thun, M. J. (2003) Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: Results from Cancer Prevention Study II. Cancer Research, 63, pp. 6556-6562.
38. Fong, G. T. and Borland, R. and Hastings, G. and Cummings, K. M. (2004, February) In Evaluating and building an evidence base for the Framework Convention on Tobacco Control: Recent findings from the International Tobacco Control Policy Evaluation Survey [pp.].
39. Food and Drug Administration. 2004. Medwatch. Retrieved June 28, 2004, from www.fda.gov/medwatch
40. Gilpin, E. A. and Emery, S. and White, M. M. and Pierce, J. P. (2002) Does tobacco industry marketing of 'light' cigarettes give smokers a rationale for postponing quitting? Nicotine & Tobacco Research, 4(Suppl. 4), pp. S147-S155.
41. Giovino, G. A. (2002) Epidemiology of tobacco use in the United States. Oncogene, 21, pp. 7326-7340.
42. Giovino, G. A. and Tomar, S. and Reddy, M. and Peddicord, J. and Zhu, R.-P. and Escobedo, L. and Eriksen, M. P.(1996) Attitudes, knowledge, and beliefs about low-yield cigarettes among adolescent and adults. In The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of U.S. cigarettes. Report of the NCI Expert Committee. Rockville MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. (Smoking and Tobacco Control Monograph No. 7; NIH Publication No. 196-4028 pp. 39-57)
43. Griffiths, R. R. and Bigelow, G. E. and Ator, N. A. (2003) Principles of initial experimental drug abuse liability assessment in humans. Drug and Alcohol Dependence, 70, pp. S41-S54.
44. Hamilton, W.L. diStefano Norton, G. Ouellette, T.K. Rhodes, W.M. Kling, R. Connolly, G.N. 2004 Smokers' responses to advertisements for regular and light cigarettes and potential reduced-exposure tobacco products. Nicotine & Tobacco Research 6 SUPPL 3 S353-S362
45. Hatsukami, D. and Benowitz, N. L. and Rennard, S. I. and Oncken, C. and Hecht, S. S. (in press) Biomarkers to assess potential reduced exposure tobacco products. Nicotine & Tobacco Research.
46. Hatsukami, D. and Henningfield, J. and Kotlyar, M. (2004) Harm reduction approaches to reducing tobacco-related mortality. Annual Review of Public Health, 25, pp. 1-19.
47. Hatsukami, D. and Lemmonds, C. and Tomar, S. (2004) Smokeless tobacco use: Harm reduction or induction approach? Preventive Medicine, 38, pp. 309-317.
48. D. and Lemmonds, C. A. and Zhang, Y. and Murphy, S. E. and Le, C. and Carmella, S. G. and Hecht, S. S. (2004) Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. Journal of the National Cancer Institute, 96, pp. 844-852.
49. Hatsukami, D. and Slade, J. and Benowitz, N. and Giovino, G. and Gritz, E. and Leischow, S. and Warner, K. (2002) Reducing tobacco harm: Research challenges and issues. Nicotine & Tobacco Research, 4(Suppl. 2), pp. S89-S101.
50. Hecht, S. S. and Murphy, S. E. and Carmella, S. G. and Zimmerman, C. L. and Losey, L. and Kramarczuk, I. and Roe, M. R. and Puumala, S. S. and Li, Y. S. and Le, C. T. and Jensen, J. and Hatsukami, D. K. (2004) Effects of reduced cigarette smoking on uptake of a tobacco-specific lung carcinogen. Journal of the National Cancer Institute, 96, pp. 107-115.
51. Houtsmuller, E. J. and Fant, R. V. and Eissenberg, T. E. and Henningfield, J. E. and Stitzer, M. L. (2002) Flavor improvement does not increase abuse liability of nicotine chewing gum. Pharmacology, Biochemistry, and Behavior, 72, pp. 559-568.
52. Houtsmuller, E. J. and Henningfield, J. E. and Stitzer, M. L. (2003) Subjective effects of the nicotine lozenge: Assessment of abuse liability. Psychopharmacology, 167, pp. 20-27.
53. Hughes, J. R. and Gust, S. W. and Keenan, R. M. and Fenwick, J. W. and Skoog, K. and Higgins, S. T. (1991) Long-term use of nicotine vs. placebo gum. Archives of General Medicine, 151, pp. 1993-1998.
54. Hurt, R. D. and Croghan, G. A. and Wolter, T. D. and Croghan, I. T. and Offord, K. P. and Williams, G. M. and Djordjevic, M. V. and Richie, J. P., Jr. and Jeffrey, A. M. (2000) Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine & Tobacco Research, 2, pp. 327-336.
55. Husten, C. and Jackson, K. and Lee, C. (2004) Cigarette smoking among adults - United States, 2002. Morbidity and Mortality Weekly Report, 53, pp. 427-431.
56. Jasinski, D. R.(1977) Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In Drug addiction I. Morphine, sedative-hypnotic and alcohol dependence. Handbook of experimental pharmacology. Heidelberg: Springer. (Vol. 45, pp. 197-258)
57. Joseph, A. M. and Hennrikus, D. and Thoele, M. J. and Krueger, R. and Hatsukami, D. (2004) Tobacco control leaders' perceptions of harm reduction. Tobacco Control, 13, pp. 108-113.
58. Keely, J. P. and Hughes, J. R. and Hirsch, T. S. (2001). In Effects of a cigarette substitute on ongoing smoking. Poster presented at the Society for Research on Nicotine and Tobacco annual meeting, Seattle, WA
59. Kotlyar, M. and Jensen, J. and Li, S. and Hatsukami, D. (2004). In Effect of smoking reduction on cardiovascular biomarkers and subjective measures. Poster presented at the Society for Research on Nicotine and Tobacco Annual Meeting, Scottsdale, AZ
60. Kozlowski, L. and Goldberg, M. and Yost, B. and White, E. and Sweeney, C. and Pillitteri, J. (1998) Smokers' misperceptions of light and ultra-light cigarettes may keep them smoking. American Journal of Preventive Medicine, 15, pp. 78-79.
61. Kozlowski, L. T. and Strasser, A. A. and Giovino, G. A. and Erickson, P. A. and Terza, J. V. (2001) Applying the risk/use equilibrium: Use medicinal nicotine now for harm reduction. Tobacco Control, 10, pp. 201-203.
62. Lee, E. and Malson, J. and Moolchan, E. and Pickworth, W. (2004) Quantitative comparisons between a nicotine delivery device (Eclipse) and conventional cigarette smoking. Nicotine & Tobacco Research, 6, pp. 95-102.
63. Lemmonds, C. and Mooney, M. and Reich, B. and Hatsukami, D. (2004) Characteristics of cigarette smokers seeking treatment for cessation vs. reduction. Addictive Behaviors, 29, pp. 357-364.
64. Lerman, C. and Niaura, R. (2002) Applying genetic approaches to the treatment of nicotine dependence. Oncogene, 21, pp. 7412-7420.
65. Leventhal, H. and Benyamini, Y. and Brownlee, S. and Diefenbach, M. and Leventhal, E. and Patrick-Miller, L. and Robitaille, C. (1997) Illness representations: Theoretical foundation. In Perceptions of health and illness: Current research and application. (pp. 19-45). Amsterdam, The Netherlands: Harwood Academic Publishers. In
66. Levy, D. T. and Mumford, E. A. and Cummings, K. M. and Gilpin, E. A. and Giovino, G. and Hyland, A. and Sweanor, D. and Warner, K. E. (2004) The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: Estimates of a panel of experts. Cancer Epidemiology, Biomarkers & Prevention, 13, pp. 1-8.
67. Lopez, A. D. and Collishaw, N. E. and Piha, T. (1994) A descriptive model of the cigarette epidemic in developed countries. Tobacco Control, 3, pp. 242-247.
68. Martin, E. G. and Warner, K. E. and Lantz, P. M. (2004) Tobacco harm reduction: What do the experts think? Tobacco Control, 13, pp. 123-129.
69. Martin, W. R. and Sloan, J. W. and Sapiro, J. D. and Jasinski, D. R. (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, pp. 245-258.
70. McNair, D. M. and Lorr, M. and Droppleman, L. F.(1992). In Profile of Mood States (manual) (Revised ed.). San Diego: Educational and Industrial Testing Service.
71. Melikian, A. A. and Djordjevic, M. and Hosey, J. and Zhang, J. and Chen, S. and Muscat, J. E. and Zang, E. and Stellman, S. D. and Richie, J. P.(2004). In Influence of gender on delivered toxins from cigarette smoke and metabolism. Poster presented at the Society for Research on Nicotine and Tobacco annual meeting, Scottsdale, AZ
72. Mendez, D. and Warner, K. E. (2004) Adult cigarette smoking prevalence: Declining as expected (not as desired). American Journal of Public Health, 94, pp. 251-252.
73. National Cancer Institute. (1997). In Changes in cigarette-related disease risk and their implication for prevention and control. Rockville MD: National Institutes of Health. (Smoking and Tobacco Control Monograph No. 8; NIH Publication No. 97-4213)
74. National Cancer Institute.(2001). In Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Bethesda MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. (Smoking and Tobacco Control Monograph No. 13; NIH Publication No. 02-5074)
75. Pérez-Stable, E. and Herrera, B. and Jacob, P., III., and Benowitz, N. (1998) Nicotine metabolism and intake in black and white smokers. The Journal of the American Medical Association, 280, pp. 152-156.
76. Perkins, K. A. (2001) Smoking cessation in women. Special considerations. CNS Drugs, 15, pp. 391-411.
77. Petty, R. and Haugtvedt, C. and Smith, S. C., Jr.(1995) Elaboration as a determinant of attitude strength: Creating attitudes that are persistent, resistant, and predictive of behavior. In Attitude strength: Antecedents and consequences. (pp. 93-130). Mahwah NJ: Lawrence Erlbaum. In
78. Petty, R. and Wegener, D.(1999) The elaboration likelihood model: Current status and controversies. In Dual process theories in social psychology. (pp. 37-72). Guilford.
79. Pickworth, W. B. and Fant, R. V. and Nelson, R. A. and Rohrer, M. S. and Henningfield, J. E. (1999) Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine & Tobacco Research, 1, pp. 357-364.
80. Pollay, R. W. and Dewhirst, T. (2002) The dark side of marketing seemingly "light" cigarettes: Successful images and failed fact. Tobacco Control, 11(Suppl. 1), pp. i18 - i31.
81. Pollay, R. W. and Dewhirst, T. (2003) A Premiere example of the illusion of harm reduction cigarettes in the 1990s. Tobacco Control, 12, pp. 322-332.
82. Prochaska, J. O. and DiClemente, C. C. and Norcross, J. C. (1992) In search of how people change: Applications to addictive behaviors. American Psychologist, 47, pp. 1102-1114.
83. Prochaska, J. O. and Goldstein, M. G. (1991) Process of smoking cessation. Implications for clinicians. Clinics in Chest Medicine, 12, pp. 727-735.
84. Rennard, S. I. and Umino, T. and Millatmal, T. and Daughton, D. M. and Manouilova, L. S. and Ullrich, F. A. and Patil, K. D. and Romberger, D. J. and Floreani, A. A. and Anderson, J. R. (2002) Evaluation of subclinical respiratory tract inflammation in heavy smokers who switch to a cigarette-like nicotine delivery device that primarily heats tobacco. Nicotine & Tobacco Research, 4, pp. 467-476.
85. Rose, J. E. and Behm, F. M. and Westman, E. C. and Johnson, M. (2000) Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacology, Biochemistry, and Behavior, 67, pp. 71-81.
86. Schneider, N. G. and Olmstead, R. E. and Nides, M. and Mody, F. V. and Otte-Colquette, P. and Doan, K. and Patel, S. (2004) Comparative testing of 5 nicotine systems: Initial use and preferences. American Journal of Health Behavior, 28, pp. 72-86.
87. Schuh, K. and Schuh, L. and Henningfield, J. and Stitzer, M. (1997) Nicotine nasal spray and vapor inhaler: Abuse liability assessment. Psychopharmacology, 130, pp. 352-361.
88. Shiffman, S. and Burton, S. L. and Pillitteri, J. L. and Gitchell, J. G. and Di Marino, M. E. and Sweeney, C. T. and Wardle, P. A. and Koehler, G. L. (2001) Test of "light" cigarette counter-advertising using a standard test of advertising effectiveness. Tobacco Control, 10(Suppl. 1), pp. i33-i40.
89. Shiffman, S. and Hughes, J. R. and Di Marino, M. E. and Sweeney, C. T. (2003) Patterns of over-the-counter nicotine gum use: Persistent use and concurrent smoking. Addiction, 98, pp. 1747-1753.
90. Shiffman, S. and Pillitteri, J. L. and Burton, S. L. and Di Marino, M. E. (2004) Smoker and ex-smoker reactions to cigarettes claiming reduced risk. Tobacco Control, 13, pp. 78-84.
91. Shiffman, S. and Pillitteri, J. L. and Burton, S. L. and Rohay, J. M. and Gitchell, J. G. (2001a) Effect of health messages about "light" and "ultra light" cigarettes on beliefs and quitting intent. Tobacco Control, 10(Suppl. 1), pp. i24-i32.
92. Shiffman, S. and Pillitteri, J. L. and Burton, S. L. and Rohay, J. M. and Gitchell, J. G. (2001b) Smokers' beliefs about "light" and quot;ultra light" cigarettes. Tobacco Control, 10(Suppl. 1), pp. i17-i23.
93. Stillman, F. A. and Cronin, K. A. and Evans, W. D. and Ulasevich, A. (2001) Can media advocacy influence newspaper coverage of tobacco: Measuring the effectiveness of the American Stop Smoking Intervention Study's (ASSIST) media advocacy strategies. Tobacco Control, 10, pp. 137-144.
94. Stratton, K. and Shetty, P. and Wallace, R. and Bondurant, S. (Eds.). (2001). In Clearing the smoke: Assessing the science base for tobacco harm reduction. Institute of Medicine, National Academies Press.
95. Substance Abuse and Mental Health Services Administration. 2004. Drug abuse warning network. Retrieved June 28, 2004, from http://dawninfo.samhsa.gov
96. Szczypka G, Emery S, Wakefield MA, Chaloupka FJ. 2003. The adaptation and use of Neilsen media research commercials ratings data to measure potential exposure to televised smoking-related advertisements. Retrieved June 29, 2004, from www.impacteen.org/generalarea_PDFs/ Nielsenpaper_051403.pdf
97. Thun, M. J. and Day-Lally, C. and Myers, D. G. and Calle, E. E. and Flanders, W. D. and Zhu, B. P. and Namboodiri, M. M. and Heath, C. W.(1997) Trends in tobacco smoking and mortality from cigarette use in Cancer Prevention Studies I (1959 through 1965) and II (1982 through 1988). In Changes in cigarette-related disease risks and their implication for prevention and control. Rockville MD: National Cancer Institute. (Smoking and Tobacco Control Monograph No. 8; NIH Publication No. 97-4213)
98. Thun, M. J. and Heath, C. W., Jr. (1997) Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Preventive Medicine, 26, pp. 422-426.
99. U. S. Department of Agriculture. Tobacco outlook (No. TBS-257) Washington, DC: Author, Economic Research Service.
100. U. S. Department of Health and Human Services. Tobacco use among U.S. racial/ethnic groups - African Americans, American Indian and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
101. Wagenknecht, L. E. and Cutter, G. R. and Haley, N. J. (1990) Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults Study. American Journal of Public Health, 80, pp. 1053-1056.
102. Wakefield, M. A. and Chaloupka, F. J. (1998) Improving the measurement and use of tobacco control "inputs." Tobacco Control, 7, pp. 333-335.
103. Warner, K. E. and Martin, E. G. (2003) The U.S. tobacco control community's view of the future of tobacco harm reduction. Tobacco Control, 12, pp. 383-390.
104. Wennike, P. and Danielsson, T. and Landfeldt, B. and Westin, A. and Tonnesen, P. (2003) Smoking reduction promotes smoking cessation: Results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction, 98, pp. 1395-1402.
105. West, R. and Hajek, P. and Foulds, J. and Nilsson, F. and May, S. and Meadows, A. (2000) A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler Psychopharmacology, 149, pp. 198-202.
106. Westman, E. C. and Levin, E. D. and Rose, J. E. (1992) Smoking while wearing the nicotine patch: Is smoking satisfying or harmful? Clinical Research, 40, pp. 871A.
107. World Health Organization Scientific Advisory Committee on Tobacco Product Regulation. 2003. Statement of principles guiding the evaluation of new or modified tobacco products. Retrieved from http://whqlibdoc.who.int/publications/2003/9241590513.pdf
108. World Health Organization Study Group on Tobacco Product Regulation. 2003. Guiding principles for the development of tobacco product research and testing capacity and proposed protocols for the initiation of tobacco product testing. Retrieved from www.who.int/tobacco/ global_interaction/tobreg/goa_2003_principles/en